AA
VERA icon

ALPS Advisors’s Vera Therapeutics VERA Stock Holding History

ALPS Advisors’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.11M Buy
72,557
+14,470
+25% +$539K 0.01% 390
2026
Q1 		$2.34M Buy
58,087
+5,695
+11% +$245K 0.01% 375
2025
Q4 		$2.65M Buy
52,392
+21,642
+70% +$769K 0.02% 348
2025
Q3 		$894K Sell
30,750
-3,691
-11% -$85.4K 0.01% 555
2025
Q2 		$811K Sell
34,441
-12,071
-26% -$271K ﹤0.01% 564
2025
Q1 		$1.12M Sell
46,512
-4,695
-9% -$151K 0.01% 453
2024
Q4 		$2.17M Buy
51,207
+6,941
+16% +$307K 0.01% 338
2024
Q3 		$1.96M Buy
44,266
+1,432
+3% +$54.3K 0.01% 363
2024
Q2 		$1.55M Buy
42,834
+4,102
+11% +$163K 0.01% 376
2024
Q1 		$1.67M Buy
38,732
+8,512
+28% +$303K 0.01% 381
2023
Q4 		$465K Sell
30,220
-2,490
-8% -$31.6K ﹤0.01% 617
2023
Q3 		$448K Buy
32,710
+175
+0.5% +$3K ﹤0.01% 611
2023
Q2 		$522K Buy
32,535
+4,906
+18% +$44.3K ﹤0.01% 608
2023
Q1 		$214K Buy
27,629
+8,880
+47% +$68.5K ﹤0.01% 979
2022
Q4 		$363K Buy
18,749
+4,005
+27% +$72.5K ﹤0.01% 720
2022
Q3 		$314K Sell
14,744
-1,316
-8% -$24.6K ﹤0.01% 708
2022
Q2 		$219K Buy
+16,060
New +$280K ﹤0.01% 980

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ALPS Advisors's VERA Position: Q2 2026 in Review

ALPS Advisors increased its Vera Therapeutics (VERA) stake by 25% in Q2 2026, buying an estimated $539K and bringing the position to 72,557 shares worth $3.11M. The position accounts for 0.01% of the portfolio, ranked #390.

ALPS Advisors first reported a position in VERA in Q2 2022 and has held it in 17 quarters since. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • ALPS Advisors held 72,557 shares of Vera Therapeutics worth $3.11M as of Q2 2026.
  • ALPS Advisors bought 14,470 Vera Therapeutics shares in Q2 2026, an estimated $539K.
  • Vera Therapeutics made up 0.01% of ALPS Advisors's portfolio in Q2 2026, its #390 holding.
  • ALPS Advisors first reported a position in Vera Therapeutics in Q2 2022 and has held it in 17 quarters since.
  • 220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.